Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Sponsored by RegeneronPlease see full Prescribing Info, together with Remedy Information.Are you serving to a liked one navigate a complicated non-small cell...
The nineteenth annual DONNA Marathon Weekend concluded Sunday with greater than 9,700 runners registered in occasions throughout the First Coast. Athletes from...
